Which represents a major practical limitation of pharmacotherapy?

• A. High cost
• B. Availability in all markets
• C. Lack of compliance due to adverse effects
• D. Too rapid onset of action

Answer: (C)

The main concept is that real-world effectiveness of drugs hinges on how well patients can tolerate and adhere to a therapy. Adverse effects often drive people to skip doses, delay refills, or stop the medication altogether, which means the medicine can’t work as intended even if it’s pharmacologically powerful. This lack of compliance due to side effects is a major practical limitation because it directly reduces the actual benefit seen in everyday use, not just in idealized clinical trials.

In practice, even highly effective drugs fail to deliver if patients won’t take them consistently. That’s why managing tolerability, patient education, and choosing regimens with fewer or more manageable adverse effects are crucial parts of pharmacotherapy.

Cost or market availability can be barriers in specific contexts, but they’re not universal limitations of the therapy itself. An immediate, rapid onset of action is generally advantageous and not a limiting factor in the same way adverse effects that disrupt adherence are.